CJ Bioscience, Inc.

Equities

A311690

KR7311690002

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
14,790 ^KRW	+3.14%		+7.10%	-8.36%

2023	CJ Bioscience, Inc. announced that it has received KRW 24.033 billion in funding from CJ Cheiljedang Corporation	CI
2023	CJ Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

CJ Bioscience, Inc. agreed to acquire Red BIO business of CJ Cheiljedang Corporation for KRW 6.1 billion.

November 07, 2021

CJ Bioscience, Inc. (KOSDAQ:A311690) agreed to acquire Red BIO business of CJ Cheiljedang Corporation (KOSE:A097950) for KRW 6.1 billion on November 8, 2021. The transaction is expected to close on January 3, 2022.

Latest news about CJ Bioscience, Inc.

CJ Bioscience, Inc. announced that it has received KRW 24.033 billion in funding from CJ Cheiljedang Corporation	23-08-09	CI
CJ Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Provectus Algae Pty Ltd announced that it has received funding from CJ Bioscience, Inc.	23-02-28	CI
CJ Bioscience, Inc. agreed to acquire Red BIO business of CJ Cheiljedang Corporation for KRW 6.1 billion.	21-11-07	CI
CJ Cheiljedang Corporation completed the acquisition of 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd..	21-10-28	CI
ChunLab, Inc. announced that it has received KRW 73.24122766 billion in funding from CJ Cheiljedang Corporation	21-10-28	CI
CJ Cheiljedang Corporation signed a stock purchase contract to acquire 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd. for KRW 25 billion.	21-07-20	CI
ChunLab, Inc. announced that it expects to receive KRW 73.24122766 billion in funding from CJ Cheiljedang Corporation	21-07-20	CI
ChunLab, Inc. announced that it has received KRW 30 billion in funding	20-09-01	CI
ChunLab, Inc. announced that it expects to receive KRW 30 billion in funding	20-08-30	CI
ChunLab, Inc. has completed an IPO in the amount of KRW 17.2 billion.	19-12-25	CI
ChunLab Releases Beta Version of TrueBac ID, the Genome-Based Diagnostic Solution for Bacterial Identification	19-09-05	CI
ChunLab, Inc. has filed an IPO.	19-09-05	CI

Chart CJ Bioscience, Inc.

Duration

Period

More charts

Company Profile

CJ Bioscience Inc, formerly ChunLab Inc, is a Korea-based company principally engaged in the provision of microbial bioinformatics platform and solutions. The Company mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The Company also develops microbiome therapies and infection diagnosis solutions.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CJ BIOSCIENCE, INC.	-8.36%	94.99M
IQVIA HOLDINGS INC.	+0.48%	42.86B
MODERNA, INC.	+12.08%	42.74B
LONZA GROUP AG	+44.30%	41.36B
CELLTRION, INC.	-6.20%	27.68B
ICON PUBLIC LIMITED COMPANY	+5.51%	25.15B
ALNYLAM PHARMACEUTICALS, INC.	-23.98%	18.63B
MEDPACE HOLDINGS, INC.	+27.52%	12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.74%	11.92B
UNITED THERAPEUTICS CORPORATION	+7.19%	11.21B

Other Biotechnology & Medical Research